Literature DB >> 19370421

A novel complex BRAF mutation detected in a solid variant of papillary thyroid carcinoma.

Simion Chiosea1, Marina Nikiforova, Hui Zuo, Jennifer Ogilvie, Manoj Gandhi, Raja R Seethala, N Paul Ohori, Yuri Nikiforov.   

Abstract

BRAF gene mutations are identified in about 45% of papillary thyroid carcinomas (PTC) and represent the most common genetic event in this tumor. Here, we report a case of PTC, solid variant, with a complex BRAF mutation that involves one nucleotide substitution, C1796T, and a CTT triplet insertion, 1798_1799insCTT, located on the same allele. This mutation leads to the replacement of a threonine with an isoleucine, T599I, and replacement of a valine with an alanine and a leucine, V600delinsAL. This mutation was identified both in the preoperative fine needle aspirate sample and in the surgical specimen after total thyroidectomy. Other rare BRAF mutations in PTC are reviewed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19370421     DOI: 10.1007/s12022-009-9073-3

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  29 in total

1.  A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma.

Authors:  Vítor Trovisco; Paula Soares; Ricardo Soares; João Magalhães; Pedro Sá-Couto; Manuel Sobrinho-Simões
Journal:  Hum Pathol       Date:  2005-06       Impact factor: 3.466

2.  Functional characterization of the T1799-1801del and A1799-1816ins BRAF mutations in papillary thyroid cancer.

Authors:  Peng Hou; Dingxie Liu; Mingzhao Xing
Journal:  Cell Cycle       Date:  2007-02-05       Impact factor: 4.534

3.  Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma.

Authors:  Libero Santarpia; Steven I Sherman; Anna Marabotti; Gary L Clayman; Adel K El-Naggar
Journal:  Hum Pathol       Date:  2009-02-05       Impact factor: 3.466

4.  The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma.

Authors:  Tae Yong Kim; Won Bae Kim; Yoon Soo Rhee; Ja Young Song; Jung Min Kim; Gyungyub Gong; Seungkoo Lee; Sang Yoon Kim; Seong Chul Kim; Suck Joon Hong; Young Kee Shong
Journal:  Clin Endocrinol (Oxf)       Date:  2006-09       Impact factor: 3.478

5.  Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis.

Authors:  Thomas J Giordano; Rork Kuick; Dafydd G Thomas; David E Misek; Michelle Vinco; Donita Sanders; Zhaowen Zhu; Raffaele Ciampi; Michael Roh; Kerby Shedden; Paul Gauger; Gerard Doherty; Norman W Thompson; Samir Hanash; Ronald J Koenig; Yuri E Nikiforov
Journal:  Oncogene       Date:  2005-10-06       Impact factor: 9.867

6.  The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane.

Authors:  G Riesco-Eizaguirre; P Gutiérrez-Martínez; M A García-Cabezas; M Nistal; P Santisteban
Journal:  Endocr Relat Cancer       Date:  2006-03       Impact factor: 5.678

Review 7.  BRAF mutation in thyroid cancer.

Authors:  M Xing
Journal:  Endocr Relat Cancer       Date:  2005-06       Impact factor: 5.678

8.  Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma.

Authors:  Giuliana Salvatore; Riccardo Giannini; Pinuccia Faviana; Alessia Caleo; Ilenia Migliaccio; James A Fagin; Yuri E Nikiforov; Giancarlo Troncone; Lucio Palombini; Fulvio Basolo; Massimo Santoro
Journal:  J Clin Endocrinol Metab       Date:  2004-10       Impact factor: 5.958

9.  Genetics of papillary thyroid cancer initiation: implications for therapy.

Authors:  James A Fagin
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

10.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

View more
  17 in total

Review 1.  Molecular analysis of thyroid tumors.

Authors:  Feriyl Bhaijee; Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2011-09       Impact factor: 3.943

2.  Solid papillary thyroid carcinoma with Hashimoto's thyroiditis: description of a further case with challenging cytological features.

Authors:  Franco Fulciniti; Jessica Barizzi; Pierpaolo Trimboli; Luca Giovanella
Journal:  BMJ Case Rep       Date:  2019-01-17

Review 3.  Molecular genetics and diagnosis of thyroid cancer.

Authors:  Yuri E Nikiforov; Marina N Nikiforova
Journal:  Nat Rev Endocrinol       Date:  2011-08-30       Impact factor: 43.330

4.  A 3-bp Deletion VK600-1E in the BRAF Gene Detected in a Young Woman with Papillary Thyroid Carcinoma.

Authors:  S Dvorakova; V Sykorova; E Vaclavikova; P Sykorova; P Vlcek; D Kodetova; P Lastuvka; J Betka; M Mokrejs; J Vcelak; B Bendlova
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

Review 5.  Molecular approaches to thyroid cancer diagnosis.

Authors:  Susan J Hsiao; Yuri E Nikiforov
Journal:  Endocr Relat Cancer       Date:  2014-05-14       Impact factor: 5.678

Review 6.  Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.

Authors:  Jinwei Hu; Isabella J Yuan; Saied Mirshahidi; Alfred Simental; Steve C Lee; Xiangpeng Yuan
Journal:  Int J Mol Sci       Date:  2021-02-16       Impact factor: 5.923

7.  Diagnostic and prognostic markers in differentiated thyroid cancer.

Authors:  José M Gómez Sáez
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

Review 8.  The utility of BRAF testing in the management of papillary thyroid cancer.

Authors:  Adrienne L Melck; Linwah Yip; Sally E Carty
Journal:  Oncologist       Date:  2010-12-08

9.  Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600).

Authors:  Alexander Skorokhod; Peter Helmbold; Benedikt Brors; Peter Schirmacher; Alexander Enk; Roland Penzel
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

10.  BRAF mutations in thyroid tumors from an ethnically diverse group.

Authors:  Hans-Juergen Schulten; Sherine Salama; Zuhoor Al-Mansouri; Reem Alotibi; Khalid Al-Ghamdi; Osman Abdel Al-Hamour; Hassan Sayadi; Hosam Al-Aradati; Adel Al-Johari; Etimad Huwait; Mamdooh Gari; Mohammed Hussain Al-Qahtani; Jaudah Al-Maghrabi
Journal:  Hered Cancer Clin Pract       Date:  2012-08-27       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.